Progyny, Inc. (PGNY) — Fair Value Analysis

Base-case fair value (P50): $30.18 · Current price: $26.28 · Verdict: Fairly Valued

The Verdict on PGNY

Based on our Monte Carlo simulations, PROGYNY INC (PGNY) is currently Fairly Valued. While the stock trades at $26.28, our median fair value (P50) stands at $30.18. This implies a potential +14.8% upside to its intrinsic value, positioning PGNY as adequately priced given its current fundamentals and market context. This assessment is derived from thousands of forward-looking scenarios, weighing various operational and financial factors.

How PGNY stacks up against peers

PGNY exhibits a strong quality tier, indicating robust operational and financial health relative to its sector peers. This strong fundamental positioning provides a solid underpinning for its current valuation and the +14.8% implied by our P50 fair value of $30.18. Even with its present trading price of $26.28, PGNY's strong quality suggests a degree of resilience, justifying its "Fairly Valued" verdict despite not offering substantial immediate upside. The market appears to be recognizing this underlying strength.

What this means for investors

For investors eyeing PROGYNY INC, the "Fairly Valued" verdict suggests that the stock at $26.28 is largely reflective of its intrinsic worth. The +14.8% implied by our $30.18 median fair value indicates that while significant undervaluation is not present, there's still a reasonable margin for appreciation. Given its strong quality tier, PGNY could appeal to investors seeking fundamentally sound companies without necessarily chasing extreme discount opportunities. To understand the full range of potential outcomes, including detailed bear and bull case distributions for PGNY, sign up for a free FairCurve account to track its fair value as new fundamentals are released.